Eucrisa

Active Ingredient(s): Crisaborole
FDA Approved: * December 14, 2016
Pharm Company: * ANACOR PHARMS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eucrisa Overview

Crisaborole (trade name Eucrisa) is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis (eczema) in people two years or older.[1][2] It was approved by U.S. Food and Drug Administration on Dec 14, 2016.[3] Contents 1 Mechanism of action 2 Chemistry 3 History 4 See also 5 References Mechanism of action It is a phosphodiesterase-4 inhibitor, mainly acting on phosphodiesterase 4B (PDE4B), which c...

Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Crisaborole

Recent Eucrisa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Eucrisa: (1 result)

Sorted by National Drug Code

• 55724-211 Eucrisa 20 mg/g Topical Ointment by Anacor Pharmaceuticals, Inc.

Other drugs which contain Crisaborole or a similar ingredient: (1 result)

• CRISABOROLE